Inhibition of XIAP increases carboplatin sensitivity in ovarian cancer
Yiping Zhang,1,2 Furong Huang,3 Qingyu Luo,3 Xiaowei Wu,3 Zhihua Liu,3 Hongyan Chen,3 Yinghui Huang1 1Cancer Institute, College of Life Science and Bioengineering, Beijing University of Technology, Beijing, China; 2China National Center for Biotechnology Development, Beijing, China; 3The State Key...
Main Authors: | Zhang Y, Huang F, Luo Q, Wu X, Liu Z, Chen H, Huang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/inhibition-of-xiap-increases-carboplatin-sensitivity-in-ovarian-cancer-peer-reviewed-article-OTT |
Similar Items
-
Intraperitoneal, Continuous Carboplatin Delivery for the Treatment of Ovarian Cancer
by: Zhidkov, Nickholas
Published: (2012) -
Intraperitoneal, Continuous Carboplatin Delivery for the Treatment of Ovarian Cancer
by: Zhidkov, Nickholas
Published: (2012) -
Downregulation Of LncRNA PMS2L2 In Endometrial Adenocarcinoma Upon Carboplatin Treatment
by: Zhang D, et al.
Published: (2019-10-01) -
MiR-124-3p.1 Sensitizes Ovarian Cancer Cells to Mitochondrial Apoptosis Induced by Carboplatin
by: Deng X, et al.
Published: (2020-06-01) -
Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015-07-01)